This trial is enrolling now. Depending on eligibility and available places in your area, you may be able to enrol in this trial.
The aim of this project is to see whether it's a good idea to include a pharmacist in your care plan.
People will be randomisedA method based on chance by which study participants are assigned to a treatment group. Randomization minimizes the differences among groups by equally distributing people with particular characteristics among all the trial arms. The researchers do not know which treatment is better. From what is known at the time, any one of the treatments chosen could be of benefit to the participant into one of two arms: they'll either be seen by their usual doctor and their care will be managed in the usual way; or they'll be seen by their usual doctor plus a prescribing pharmacist, an agreed care plan will be produced and their subsequent appointments during the project will be managed by the prescribing pharmacist.
Consultations will be audio-recorded and compared to see which method is more efficient and effective for both patients and doctors.
The Evaluation of the Impacts of a Doctor – Pharmacist Collaborative Prescribing Model on the Management of Human Immunodeficiency Virus (HIV) Infected Patients
other
March 2009 (This may be the proposed or expected start date for trials which have not yet started.)
100 (The exact number of participants may be lower or slightly higher than this. Some trials also have specific quotas for participants from each state, city or clinic.)
Participants in this trial will be asked to follow the trial protocol for 12 months.
You may be eligible to participate in this trial if you meet the following criteria:
This is a summary of key inclusion and exclusion criteria for this trial. There may be other criteria which may exclude some people from participation in this trial. Some laboratory tests may also be required. Consult your doctor, or view the trial protocol or informed consent documentation to see the full range of exclusion and inclusion criteria.
Before making the decision to participate in any clinical trial, NAPWA recommends that you discuss the potential benefits and risks of participation with your treating doctor. Your doctor can also provide advice about your eligibility to participate in the trial.
While NAPWA has taken every care to compile the information on this page and to keep it up-to-date, we cannot guarantee its correctness and completeness.
Before making the decision to participate in any clinical research, visit the NAPWA website for background information on participating in clinical research.
Contact NAPWA if you have any questions or comments about this trial.